Due to its rapid geographic spread over the last two decades, the coronavirus has become a global health issue. Due to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic has resulted in a worldwide abrupt and significant increase in hospitalizations for pneumonia with multiorgan disease. Droplets produced during face-to-face encounters when talking, coughing, or sneezing appear to be the most common mechanism of transmission, according to epidemiologic data. COVID-19 is usually diagnosed by testing a nasopharyngeal swab with a polymerase chain reaction. Given the risk of false-negative test results, clinical, laboratory, and imaging evidence may be used to make a presumptive diagnosis in patients with a high index of clinical suspicion of infection. Quarantine appears to be the only intervention that appears to be helpful in lowering the contagion rate, despite the fact that various medicines have been recommended. To find the most appropriate evidence-based therapy modality, especially designed randomised clinical trials are required.